Results 311 to 320 of about 517,111 (322)
Some of the next articles are maybe not open access.

Pathophysiology of Interleukin-23 in Experimental Autoimmune Encephalomyelitis

Drug News & Perspectives, 2006
Interleukin-23 (IL-23) is a heterodimeric cytokine that is composed of a p40 subunit, shared with the closely related cytokine IL-12, and a smaller IL-23p19 subunit. It belongs to a family of heterodimeric cytokines that also includes IL-12 and IL-27.
Tarik, Touil   +4 more
openaire   +2 more sources

The critical role of interleukin-23 in spondyloarthropathy

Molecular Immunology, 2014
The spondyloarthropathies represent highly enigmatic conditions and although their clinical features, anatomical distribution of disease and genetic predisposing factors have been known for some time, a unified concept of the basic pathobiology underlying these illnesses has remained undefined.
Jonathan P, Sherlock   +2 more
openaire   +2 more sources

Interleukin-23

2021
Christine Huppertz   +1 more
openaire   +1 more source

Interleukin 23 Inhibitors

2021
Erica B. Lee, Mina Amin, Jashin J. Wu
openaire   +1 more source

Spondyloarthropathy: interleukin 23 and disease modification

The Lancet, 2015
Jonathan P, Sherlock   +3 more
openaire   +2 more sources

Interleukin 23

2015
Ahmet Eken   +2 more
openaire   +1 more source

Dauerhaftes Therapieansprechen unter Interleukin-23-Inhibitor

ästhetische dermatologie & kosmetologie, 2023
openaire   +1 more source

Neues Biologikum blockt Interleukin-23

Der Deutsche Dermatologe, 2018
openaire   +1 more source

Home - About - Disclaimer - Privacy